NIH signs 10-year deal to fund Pentagon biodefense research from NIAID budget
The NIH and Department of Defense have quietly confirmed a signed agreement, disclosed the Friday before a US holiday, that redirects part of the NIH's National Institute of Allergy and Infectious Diseases budget toward Pentagon research on pandemic flu, CBRN threats and emerging infectious diseases. The deal runs a decade, and while the exact dollar amount is unspecified, reports indicate the Pentagon sought roughly a third of relevant funding but was steered toward about 10 percent instead.